Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2006 1
2008 2
2010 4
2012 2
2013 3
2014 8
2015 3
2016 7
2017 3
2018 6
2019 6
2020 3
2021 2
2022 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

49 results

Results by year

Filters applied: . Clear all
Page 1
Prediction of esophagogastric varices associated with oxaliplatin administration.
Satta Y, Shigefuku R, Watanabe T, Mizukami T, Tsuda T, Suzuki T, Ehira T, Hattori N, Kiyokawa H, Nakahara K, Ikeda H, Matsunaga K, Takahashi H, Matsumoto N, Okuse C, Suzuki M, Sunakawa Y, Yasuda H, Itoh F. Satta Y, et al. Among authors: matsunaga k. JGH Open. 2021 Nov 2;5(11):1289-1297. doi: 10.1002/jgh3.12668. eCollection 2021 Nov. JGH Open. 2021. PMID: 34816015 Free PMC article.
A prospective observational cohort study of lenvatinib as initial treatment in patients with BCLC-defined stage B hepatocellular carcinoma.
Kobayashi S, Fukushima T, Ueno M, Moriya S, Chuma M, Numata K, Tsuruya K, Hirose S, Kagawa T, Hattori N, Watanabe T, Matsunaga K, Suzuki M, Uojima H, Hidaka H, Kusano C, Suzuki M, Morimoto M. Kobayashi S, et al. Among authors: matsunaga k. BMC Cancer. 2022 May 7;22(1):517. doi: 10.1186/s12885-022-09625-x. BMC Cancer. 2022. PMID: 35525913 Free PMC article.
Comparative study between sorafenib and lenvatinib as the first-line therapy in the sequential treatment of unresectable hepatocellular carcinoma in a real-world setting.
Fukushima T, Morimoto M, Ueno M, Kubota K, Uojima H, Hidaka H, Chuma M, Numata K, Tsuruya K, Hirose S, Kagawa T, Hattori N, Watanabe T, Matsunaga K, Yamamoto K, Tanaka K, Maeda S. Fukushima T, et al. Among authors: matsunaga k. JGH Open. 2021 Dec 17;6(1):29-35. doi: 10.1002/jgh3.12691. eCollection 2022 Jan. JGH Open. 2021. PMID: 35071785 Free PMC article.
Risk factors for liver-related mortality of patients with hepatitis C virus after sustained virologic response to direct-acting antiviral agents.
Hattori N, Ikeda H, Watanabe T, Satta Y, Ehira T, Suzuki T, Kiyokawa H, Nakahara K, Takahashi H, Matsunaga K, Matsumoto N, Yasuda H, Suzuki M, Itoh F, Tateishi K. Hattori N, et al. Among authors: matsunaga k. JGH Open. 2022 Aug 26;6(10):685-691. doi: 10.1002/jgh3.12805. eCollection 2022 Oct. JGH Open. 2022. PMID: 36262540 Free PMC article.
Endoscopic Transpapillary Gallbladder Drainage for Acute Cholecystitis After Biliary Self-Expandable Metal Stent Placement.
Nakahara K, Morita R, Michikawa Y, Suetani K, Morita N, Fujita A, Sato J, Igarashi Y, Ikeda H, Matsunaga K, Watanabe T, Kobayashi S, Otsubo T, Itoh F. Nakahara K, et al. Among authors: matsunaga k. Surg Laparosc Endosc Percutan Tech. 2020 Oct;30(5):416-423. doi: 10.1097/SLE.0000000000000802. Surg Laparosc Endosc Percutan Tech. 2020. PMID: 32398448
Progression pattern and post-progression survival following atezolizumab and bevacizumab treatment in advanced hepatocellular carcinoma.
Kobayashi S, Fukushima T, Ueno M, Chuma M, Numata K, Tsuruya K, Arase Y, Hirose S, Kagawa T, Hattori N, Watanabe T, Matsunaga K, Uojima H, Hidaka H, Kusano C, Morimoto M, Maeda S. Kobayashi S, et al. Among authors: matsunaga k. Liver Int. 2024 Mar 4. doi: 10.1111/liv.15825. Online ahead of print. Liver Int. 2024. PMID: 38436529
49 results